McCormick & Co Inc/ US5797802064 /
2024-08-30 9:59:50 PM | Chg. +0.97 | Volume | Bid10:25:00 PM | Ask10:25:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
80.01USD | +1.23% | 49,562 Turnover: 1.97 mill. |
-Bid Size: - | -Ask Size: - | 21.5 bill.USD | 1.95% | 31.51 |
GlobeNewswire
08-20
Rendering Speculation Unnecessary, TrustCo Delivers Again With a Quarterly Dividend of $0.36 Per Sha...
GlobeNewswire
08-20
Lone Star PACE Facilitates $27M in Retroactive C-PACE Financing for Luxury Hotel in Dallas Arts Dist...
GlobeNewswire
07-31
Package with Paper or Poly on PAC Machinery’s new Rollbag® R3200 Fulfillment Paper Auto Bagger
GlobeNewswire
07-22
TrustCo Delivers Once Again With Second Quarter Results Net Interest Margin Up 3.7% on Loan Growth o...
GlobeNewswire
07-18
Lone Star PACE Hires Tenured Communications Strategist to Lead Marketing Efforts
GlobeNewswire
07-16
Trustco Bank Announces Management Changes – Leonard, Curley, and Others Assume New Roles
GlobeNewswire
07-09
Aqualab Lead Food Scientist, Zachary Cartwright, PhD, Takes Leadership Role at IFT First Annual Even...
GlobeNewswire
06-25
Ingersoll Rand Names Scott Watson as Leader for Life Science Technologies Platform
GlobeNewswire
06-06
Dozens of @properties Christie’s International Real Estate Agents Named to Prestigious 2024 RealTren...
GlobeNewswire
06-03
Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-li...
GlobeNewswire
06-02
Precede Biosciences Presents New Data at ASCO 2024 Demonstrating Accurate HER2 Status Detection Acro...
GlobeNewswire
06-01
Y-mAbs Announces Publication of Preclinical GD2-SADA Data at 2024 ASCO Annual Meeting
GlobeNewswire
06-01
Y-mAbs Announces New Interim Analysis of Phase 2 Data for Naxitamab at 2024 ASCO Annual Meeting
GlobeNewswire
05-30
Ispire Technology Inc. to Present at the KCSA Cannabis Virtual Investor Conference June 5th
GlobeNewswire
05-30
Sermonix Pharmaceuticals to Present Poster on ELAINE-3 Trial in Progress at ASCO 2024